By: Adam Feuerstein | 07/22/14 - 12:12 PM EDT
Survey: how high do $GILD's Sovaldi sales need to be tomorrow to move the stock up? — Meg Tirrell (@megtirrell) July 22, 2014To which I replied:
. @megtirrell There probably is no Sovaldi sales number high enough to prevent $GILD post-earning sell off. Short term trading… ZZZzzzzz — Adam Feuerstein (@adamfeuerstein) July 22, 2014The buyside "whisper number" for Sovaldi sales in the June quarter stands at $3.5 billion. But everyone who follows Gilead knows this, which means the "whispered" whisper number for sales of the blockbuster hepatitis C drug is probably more like $4 billion or more.
10/29/14 - 09:16 AM EDT
10/29/14 - 07:30 AM EDT
10/27/14 - 11:02 AM EDT
10/22/14 - 11:52 AM EDT
10/22/14 - 08:39 AM EDT
10/31/14 - 11:06 AM EDT
10/31/14 - 10:54 AM EDT
10/30/14 - 10:45 AM EDT
10/29/14 - 09:58 AM EDT
10/29/14 - 09:40 AM EDT
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.